NVS Novartis AG

FRANKFURT--The following is a summary of analysts' forecasts for Novartis AG (NVS) third-quarter results, based on a poll of six analysts conducted by Dow Jones Newswires (figures in million dollars, EPS in dollar, DPS and target price in Swiss francs, according to IFRS). Earnings figures are scheduled to be released October 25.

=== 
              Net sales: 
3rd Quarter      -Total -Pharma -Diovan  -Gleevec -Lucentis 
AVERAGE          12,186   8,074     252       744       446 
Prev. Year       12,265   8,254     287     1,185       485 
+/- in %           -0.6    -2.2     -12       -37      -8.0 
 
MEDIAN           12,182   8,090     259       735       454 
Maximum          12,251   8,192     275       826       464 
Minimum          12,104   7,944     215       684       412 
Amount                6       6       4         6         5 
 
Bernstein        12,248   8,087     259       711       443 
Deutsche Bank    12,251   8,192     275       826       464 
Jefferies        12,104   7,944     258       684       454 
Kepler Cheuvreux 12,192   8,093      --       724       459 
Morgan Stanley   12,172   8,125      --       746        -- 
Zuercher KB      12,148   8,004     215       770       412 
 
                   Core: 
                 -Operating  -Net attrib. 
3rd Quarter          income       profit   -EPS 
AVERAGE               3,291        2,764   1.22 
Prev. Year            3,489        2,988   1.27 
+/- in %               -5.7         -7.5   -4.3 
 
MEDIAN                3,261        2,863   1.21 
Maximum               3,413        2,965   1.24 
Minimum               3,233        2,200   1.20 
Amount                    6            5      6 
 
Bernstein             3,250        2,861   1.20 
Deutsche Bank         3,413        2,965   1.24 
Jefferies             3,267        2,863   1.20 
Kepler Cheuvreux      3,331        2,929   1.23 
Morgan Stanley        3,233           --   1.22 
Zuercher KB           3,254        2,200   1.20 
 
 
            Target price  Rating                   DPS 2016 
AVERAGE            93.20  positive 5  AVERAGE          2.70 
Prev. Quarter      89.50  neutral  1  Prev. Year       2.70 
+/- in %            +4.1  negative 1  +/- in %         -0.1 
 
MEDIAN             94.00              MEDIAN           2.73 
Maximum           100.00              Maximum          2.75 
Minimum            85.00              Minimum          2.59 
Amount                 5              Amount              4 
 
Baader-Helvea     100.00  Buy                            -- 
Bernstein          90.00  Outperform                     -- 
Deutsche Bank      85.00  Hold                         2.59 
Jefferies          97.00  Buy                          2.70 
Kepler Cheuvreux   94.00  Buy                          2.75 
Morgan Stanley        --  Underweight                    -- 
Zuercher KB           --  Overweight                   2.75 
=== 

Year-earlier figures are as reported by the company - continued operations.

DJG/err 

(END) Dow Jones Newswires

October 21, 2016 07:59 ET (11:59 GMT)

Novartis (NYSE:NVS)
Historical Stock Chart
From Mar 2024 to Apr 2024

Novartis (NYSE:NVS)
Historical Stock Chart
From Apr 2023 to Apr 2024